(PharmaNewsWire.Com, September 01, 2017 ) Global Antibody Drug Conjugate market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Seattle Genetics/Takeda Roche ImmunoGen Immunomedics Pfizer Celldex Therapeutics Millennium Pharmaceuticals Bayer HealthCare Mersana Therapeutics Heidelberg Pharma Oxford BioTherapeutics Takeda Pharmaceutical Company Limited
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD) , market share and growth rate of Antibody Drug Conjugate in these regions, from 2012 to 2022 (forecast) , covering North America Europe China Japan Southeast Asia India
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Adcetris Kadcyl On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales) , market share and growth rate of Antibody Drug Conjugate for each application, including Hospital Research Institutions
3 Global Antibody Drug Conjugate Capacity, Production, Revenue (Value) by Region (2012-2017) 3.1 Global Antibody Drug Conjugate Capacity and Market Share by Region (2012-2017) 3.2 Global Antibody Drug Conjugate Production and Market Share by Region (2012-2017) 3.3 Global Antibody Drug Conjugate Revenue (Value) and Market Share by Region (2012-2017) 3.4 Global Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.5 North America Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.6 Europe Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.7 China Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.8 Japan Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.9 Southeast Asia Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.10 India Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
5 Global Antibody Drug Conjugate Production, Revenue (Value) , Price Trend by Type 5.1 Global Antibody Drug Conjugate Production and Market Share by Type (2012-2017) 5.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2012-2017) 5.3 Global Antibody Drug Conjugate Price by Type (2012-2017) 5.4 Global Antibody Drug Conjugate Production Growth by Type (2012-2017)
4 Global Antibody Drug Conjugate Supply (Production) , Consumption, Export, Import by Region (2012-2017) 4.1 Global Antibody Drug Conjugate Consumption by Region (2012-2017) 4.2 North America Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.3 Europe Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.4 China Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.5 Japan Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.6 Southeast Asia Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.7 India Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)
5 Global Antibody Drug Conjugate Production, Revenue (Value) , Price Trend by Type 5.1 Global Antibody Drug Conjugate Production and Market Share by Type (2012-2017) 5.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2012-2017) 5.3 Global Antibody Drug Conjugate Price by Type (2012-2017) 5.4 Global Antibody Drug Conjugate Production Growth by Type (2012-2017)
6 Global Antibody Drug Conjugate Market Analysis by Application 6.1 Global Antibody Drug Conjugate Consumption and Market Share by Application (2012-2017) 6.2 Global Antibody Drug Conjugate Consumption Growth Rate by Application (2012-2017) 6.3 Market Drivers and Opportunities 6.3.1 Potential Applications 6.3.2 Emerging Markets/Countries
4 Global Antibody Drug Conjugate Supply (Production) , Consumption, Export, Import by Region (2012-2017) 4.1 Global Antibody Drug Conjugate Consumption by Region (2012-2017) 4.2 North America Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.3 Europe Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.4 China Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.5 Japan Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.6 Southeast Asia Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017) 4.7 India Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)
5 Global Antibody Drug Conjugate Production, Revenue (Value) , Price Trend by Type 5.1 Global Antibody Drug Conjugate Production and Market Share by Type (2012-2017) 5.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2012-2017) 5.3 Global Antibody Drug Conjugate Price by Type (2012-2017) 5.4 Global Antibody Drug Conjugate Production Growth by Type (2012-2017)
6 Global Antibody Drug Conjugate Market Analysis by Application 6.1 Global Antibody Drug Conjugate Consumption and Market Share by Application (2012-2017) 6.2 Global Antibody Drug Conjugate Consumption Growth Rate by Application (2012-2017) 6.3 Market Drivers and Opportunities 6.3.1 Potential Applications 6.3.2 Emerging Markets/Countries
7 Global Antibody Drug Conjugate Manufacturers Profiles/Analysis 7.1 Seattle Genetics/Takeda 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.1.2 Antibody Drug Conjugate Product Category, Application and Specification 7.1.2.1 Product A 7.1.2.2 Product B 7.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.1.4 Main Business/Business Overview 7.2 Roche 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.2.2 Antibody Drug Conjugate Product Category, Application and Specification 7.2.2.1 Product A 7.2.2.2 Product B 7.2.3 Roche Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.2.4 Main Business/Business Overview 7.3 ImmunoGen 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 7.3.2 Antibody Drug Conjugate Product Category, Application and Specification 7.3.2.1 Product A 7.3.2.2 Product B 7.3.3 ImmunoGen Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 7.3.4 Main Business/Business Overview
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
